FIELD: organic chemistry, biochemistry. SUBSTANCE: invention describes novel substituted imides of the general formula (I) where Y means or ; m = 0-3; R5 means: unsubstituted o-phenylene or o-phenylene substituted with one or more substitutes each of that is taken independently from nitro-group, C1-4-alkyl, amine, carbamoyl substituted with C1-3-alkyl, acetoxy-, carboxy-, hydroxy-, amino-group substituted with C1-3-alkyl or bivalent residue of pyridine, pyrrolidine, imidazole, naphthalene or thiophene; R6 means -CO-, -CH2-, -CH2CO-, SO2; R7 means phenyl substituted with two substitutes taken independently among unbranched or cyclic C1-C10-alkoxy-group; n = 0, 1, 2 or 3. Invention relates also to method of decrease of levels of tumor necrosis α-factor, method of inhibition of activity of phosphodiesterase and to pharmaceutical composition. These compounds are inhibitors of tumor necrosis α-factor and phosphodiesterase and can be used for control against cachexia, endotoxic shock, replication of retroviruses, asthma and inflammatory states. EFFECT: improved method of decrease of tumor necrosis factor levels and inhibition of phosphodiesterase activity. 5 cl
Title |
Year |
Author |
Number |
2,6-DIOXOPIPERIDINE, METHOD FOR REDUCTION OF UNDESIRABLE LEVELS OF TNF-ALPHA IN MAMMAL, PHARMACEUTICAL COMPOSITION |
1998 |
- Maller Dzhordzh U.
- Sterling Dejvid I.
- Chen Rodzher Shen-Chu
|
RU2209207C2 |
SUBSTITUTED AMIDES, METHOD OF DECREASE OF TNF LEVEL, METHOD OF INHIBITION OF TNF-ACTIVATED REPLICATION OF RETROVIRUSES AND PHARMACEUTICAL COMPOSITION |
1995 |
- Dzhordzh Mjuller
- Meri Shir
- Dehvid I. Stirling
|
RU2162078C2 |
IMMUNOTHERAPEUTIC IMIDES/AMIDES AS INHIBITORS OF PHOSPHODI-ESTERASE-IV (PDE-IV) AND TUMOR NECROSIS FACTOR (TNF) |
1997 |
- Maller Dzhordzh U.
- Shajr Mehri
- Sterling Dejvid I.
|
RU2177471C2 |
SUCCINIMIDE AND MALEIMIDE INHIBITORS OF CYTOKINS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF TUMOR NECROSIS α-FACTOR |
1996 |
- Dzhordzh V. Mjuller
- Mehri Shajr
|
RU2176242C2 |
IMIDE/AMIDE ETHERS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF FNOK LEVEL IN MAMMALIAN |
1995 |
- Dzhordzh Mjuller
- Mehri Shir
- Dehvid I. Stirling
|
RU2164514C2 |
NOVEL IMMUNOTHERAPEUTIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND METHOD OF DECREASE OF LEVELS OF PHDE, TNF ALPHA AND NFKB |
1997 |
- Maller Dzhordzh U.
- Shajr Mehri
|
RU2188819C2 |
IMIDES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE, α, ФHO |
1996 |
- Maller Dzhordzh V.
- Shajr Mehri
|
RU2174512C2 |
SUBSTITUTED HYDROXAMIC ACIDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHOD OF TNF (TUMOR NECROSIS FACTOR) α DECREASE |
1998 |
- Maller Dzhordzh V.
- Man Khon-Vo
|
RU2199530C2 |
ARYLAMIDES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF TNF-ACTIVATED RETROVIRUS REPLICATION |
1995 |
- Dzhordzh Mjuller
- Mehri Shir
- Dehvid I. Stirling
|
RU2162839C2 |
DERIVATIVES OF 2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE, THEIR SYNTHESIS AND APPLICATION AS INHIBITORS OF INFLAMMATORY CYTOKINES |
1999 |
- Mehn Khon-Va
- Maller Dzhordzh U.
|
RU2200159C2 |